Emerging Cell Therapies: Cancer, Autoimmune Diseases, and Beyond

Mar 05–08, 2028 | Fairmont Hotel Vancouver, Vancouver, BC, Canada
Scientific Organizers: Georg A Schett, Marcela V Maus, and Gilles Besin

  Livestream
  In Person
  On Demand
×

-

Mar 05–08, 2028 | Fairmont Hotel Vancouver, Vancouver, BC, Canada

Scientific Organizers: Georg A Schett, Marcela V Maus, and Gilles Besin

Supported by:  
Important Deadlines
Early Registration Deadline: Deadlines not yet available for this meeting.
Scholarship Deadline: Deadlines not yet available for this meeting.
Short Talk Abstract Deadline: Deadlines not yet available for this meeting.
Poster Abstract Deadline: Deadlines not yet available for this meeting.
Meeting Summary

Cell therapy represents one of the most dynamic and transformative frontiers in modern medicine. Initially developed for hematological malignancies, cell-based therapies are rapidly expanding into solid tumors and autoimmune diseases, creating unprecedented opportunities to treat—and potentially cure—severe, chronic, and historically fatal conditions.


This Keystone Symposia conference on Emerging Cell Therapies: Cancer, Autoimmune Diseases, and Beyond will provide a comprehensive overview of the latest advances in cell therapy and their translation into clinical practice. The conference will focus on technological innovations in engineering cell therapies, including gene editing, vector design and construction, and cellular manufacturing, encompassing both ex vivo and emerging in vivo approaches. It will also address novel therapeutic targets, biomarkers of response and safety, treatment resistance, and the latest clinical developments. By integrating basic, translational, and clinical perspectives, the conference will identify critical knowledge gaps and define priorities for overcoming barriers to durable and effective treatment.


The conference will bring together experts from hematology, oncology, and autoimmune diseases to explore shared and disease-specific opportunities and challenges. Close interaction between clinical experts and translational researchers developing cutting-edge technologies, including in vivo CAR T-cell therapy, will promote cross-fertilization and generate innovative therapeutic concepts. Participation of scientists, clinicians, and industry representatives will further strengthen multidisciplinary collaboration and accelerate translation from discovery to clinical application.


The unprecedented pace of technological innovation, rapidly emerging clinical evidence, and expansion of cell therapy into new indications make this conference particularly timely. It will provide a unique forum to critically evaluate advances, identify remaining challenges, and define priorities for the next generation of cell therapies. A world-class program, interactive discussions, and strong academia-industry engagement will foster meaningful collaborations and generate actionable insights to accelerate the development and clinical translation of innovative cell therapies.


Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives 

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates